Change in healthcare utilization and costs following initiation of benzodiazepine therapy for long-term treatment of generalized anxiety disorder: a retrospective cohort study

被引：0
|
作者：
Ariel Berger
John Edelsberg
Michael Treglia
Jose Ma J Alvir
Gerry Oster
机构：
[1] Policy Analysis Inc. (PAI),
[2] Pfizer Inc,undefined
来源：
BMC Psychiatry | / 12卷
关键词：
Anxiety Disorders; Benzodiazepines; Utilization; Costs and Cost Analysis; Healthcare Research;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Change in healthcare utilization and costs following initiation of benzodiazepine therapy for long-term treatment of generalized anxiety disorder: a retrospective cohort study
    Berger, Ariel
    Edelsberg, John
    Treglia, Michael
    Alvir, Jose Ma J.
    Oster, Gerry
    BMC PSYCHIATRY, 2012, 12
  • [2] Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort study
    Ariel Berger
    John Edelsberg
    Vamsi Bollu
    Jose Ma J Alvir
    Ashish Dugar
    Ashish V Joshi
    Gerry Oster
    BMC Psychiatry, 11
  • [3] Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort study
    Berger, Ariel
    Edelsberg, John
    Bollu, Vamsi
    Alvir, Jose Ma J.
    Dugar, Ashish
    Joshi, Ashish V.
    Oster, Gerry
    BMC PSYCHIATRY, 2011, 11
  • [4] What are the issues surrounding long-term benzodiazepine treatment for generalized anxiety disorder?
    Lapierre, YD
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 1998, 23 (01): : 80 - 80
  • [5] Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy
    Rickels, K
    DeMartinis, N
    García-España, F
    Greenblatt, DJ
    Mandos, LA
    Rynn, M
    AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (12): : 1973 - 1979
  • [6] Long-term treatment of generalized anxiety disorder: An overview
    Scareiglia, P
    Maneschi, ML
    Regis, F
    Pancheri, P
    JOURNAL OF PSYCHOPHYSIOLOGY, 2004, 18 (01) : 48 - 48
  • [7] BUSPIRONE IN THE LONG-TERM TREATMENT OF GENERALIZED ANXIETY DISORDER
    FEIGHNER, JP
    JOURNAL OF CLINICAL PSYCHIATRY, 1987, 48 : 3 - 6
  • [8] Long-term pharmacological treatment of generalized anxiety disorder
    Mahe, V
    Balogh, A
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2000, 15 (02) : 99 - 105
  • [9] Increased healthcare utilization costs following initiation of insulin treatment in type 2 diabetes: A long-term follow-up in clinical practice
    Kalkan, Almina
    Bodegard, Johan
    Sundstrom, Johan
    Svennblad, Boa
    Ostgren, Carl Johan
    Nilsson, Peter Nilsson
    Johansson, Gunnar
    Ekman, Manias
    PRIMARY CARE DIABETES, 2017, 11 (02) : 184 - 192
  • [10] Long-term treatment of generalized social anxiety disorder with venlafaxine XR
    Hackett, D
    Stein, MB
    Mangano, R
    Pollack, M
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S380 - S381
12345